Pharmacological effects of RA 642 on cerebrocortical perfusion in acute hemorrhagic shock in rats.
Hergenröder
S
S
Department of Pharmacology, Boehringer, Ingelheim KG, Ingelheim/Rhein, Germany.
Reichl
R
R
D000818:Animals; D001160:Arterioles / Q000187:drug effects / Q000473:pathology; D001794:Blood Pressure / Q000187:drug effects; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002540:Cerebral Cortex / Q000098:blood supply; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004298:Dopamine / Q000494:pharmacology; D008833:Microcirculation / Q000473:pathology / Q000503:physiopathology; D010841:Pia Mater / Q000098:blood supply; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D012771:Shock, Hemorrhagic / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D014664:Vasodilation / Q000187:drug effects
D002316:Cardiotonic Agents; D011743:Pyrimidines; C010650:RA 642; D004298:Dopamine